MedPath

Physiotherapy in Mutated COVID-19 Patients

Not Applicable
Completed
Conditions
COVID-19 Pandemic
Interventions
Behavioral: Physiotherapy
Registration Number
NCT05874076
Lead Sponsor
Giresun University
Brief Summary

The prospective study was conducted at a single location within the COVID-19 department of a city hospital. The study included COVID-19 patients who were hospitalized in the COVID-19 service and consulted for physiotherapy, were between the ages of 18 and 65, and had the capacity and inclination to participate in one daily physiotherapy session five days per week.

Detailed Description

A hospital's COVID-19 service recruited 32 participants for the study. Patients were divided into two groups: COVID-19 (n=16; age = 53.81 9.48) and mutation (n=16; age = 55.25 10.12). Both groups underwent physiotherapy consisting of mobilization, normal range of motion, and a respiratory exercise program (COVID-19 group: 9.945.85 days; mutation group: 7.632.83 days). Every patient participated in a once-daily physiotherapy program. The patients' muscle strength, mobility, daily activities, exercise capacity, and perception of fatigue were assessed. To compare groups, the mixed repeated measures ANOVA model was used.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria

Patients with COVID-19 who were hospitalized in the COVID-19 service Patients were consulted for physiotherapy Patients with the capacity and willingness to participate in one daily physiotherapy session five days a week

Exclusion Criteria
  • Patients who had an exercise contraindication, were uncooperative, had multi-organ failure, had an acute infection, or were PEG-fed were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Covid-19 groupPhysiotherapyThis group underwent physiotherapy consisting of mobilization, normal range of motion, and a respiratory exercise program.
Mutation groupPhysiotherapyThis group underwent physiotherapy consisting of mobilization, normal range of motion, and a respiratory exercise program.
Primary Outcome Measures
NameTimeMethod
muscle strengthan average of 9 days

Using a scale developed by the Medical Research Council (MRC), muscle strength was measured. Using this instrument, the muscles of the lower and upper extremities are evaluated bilaterally. Each of the six main muscle groups evaluated receives a score between 0 (no contraction) and 5 (normal contraction).

Secondary Outcome Measures
NameTimeMethod
Exercise capacityan average of 9 days

Exercise capacity was evaluated with the 5-repetition sit to stand test (5STS).

mobility assessmentan average of 9 days

For the purpose of measuring mobility, the Rivermead Mobility Index (RMI) was applied.

Trial Locations

Locations (1)

Giresun University

🇹🇷

Giresun, Turkey

© Copyright 2025. All Rights Reserved by MedPath